HOPIN
Hopin , the leading virtual experience platform, announced today that it has acquired video hosting provider Streamable and video technology company Jamm . The technology from both companies will be integrated into Hopin’s current product offering and become the basis for the development of future video products and features. The acquisitions solidify Hopin’s focus to holistically improve its professional-grade video capabilities for organizers that host events on Hopin and to build out its suite of new, video-centric products.
“As the world reopens, high-quality virtual experiences will continue to be critical. Video will be the primary communication channel for businesses, creators and organizations to share experiences virtually, so these acquisitions are a natural next step,” said Johnny Boufarhat, founder and CEO of Hopin. “The technology and resources from Jamm and Streamable will become foundational components to future products and the entire Hopin video experience — from production and video quality to how our customers can collaborate and distribute content.”
Streamable is a popular video hosting site founded by Armen Petrosian in 2014. Petrosian has grown Streamable for the past seven years to become a leading video hosting service that has 75,000 new video uploads per day and over 5,000 paying customers in more than 100 countries. Petrosian will continue to lead Streamable’s business and help build new products at Hopin.
“At Streamable, we’ve always wanted to build products that are simple and easy to use for everyone and we recognized that Hopin’s goal to bring accessibility to events and meetings dovetailed nicely with our own goals,” said Armen Petrosian, founder and CEO of Streamable. “The first priority for Streamable will be to invest in our product suite and ultimately integrate the Streamable platform into Hopin’s future suite of products.”
Jamm was founded in 2019 by Badri Rajasekar to create a lightweight way for users to collaborate over video. Rajasekar is an expert in video technology and was previously CTO of the real-time communication API platform TokBox prior to Jamm. TokBox was acquired by Telefonica in 2012 and subsequently spun out to Vonage in 2018. Jamm hosts a number of customers including Swoop, SignEasy, Deepsource, Stackery and others across a range of industry verticals such as fintech, gaming, education and more. Rajasekar will play a key role in helping develop new features and products in-house at Hopin.
“Since I founded Jamm in 2019, we’ve seen growing interest as more businesses pursue a remote-work strategy. I’ve witnessed firsthand how productive remote teams can become when they have a video solution that’s lightweight and collaborative,” said Jamm founder and CEO Badri Rajasekar. “I’m excited to bring my expertise to Hopin and build upon the great products Johnny has already developed, to make virtual experiences even easier for Hopin customers.”
Hopin continues to see impressive demand for its products and services. In a little over a year, Hopin has grown to millions of users and more than 90,000 organizers hosting events. The two acquisitions are a continuation of Hopin’s rapid growth, as it looks to its future product roadmap to drive and meet the demand of current and future customers. Hopin recently acquired mobile app development company Topi and video streaming company StreamYard, adding StreamYard’s 3.6 million video content creators to its base. Hopin has also raised $570M to-date, with its most recent raise a $400M Series C earlier this month, co-led by Andreessen Horowitz and General Catalyst.
About Hopin
Founded in 2019, Hopin enables brands and communities to create all-in-one live video experiences for their audiences. Through its platforms, attendees can learn, interact, and connect with people from anywhere in the world. With Hopin, you can create live virtual and hybrid events that are interactive and immersive. Hopin acquired StreamYard, a leading video streaming studio, in 2020. Hopin is a remote-first company headquartered in London, with employees in 42 countries. Learn more at hopin.com.
About Streamable
Streamable is an internet video streaming company that powers innovative video experiences for thousands of creators and businesses all around the world. With Streamable, you can upload, crop, trim, embed and share videos — all without ever leaving your browser. Whether you’re just getting started or you have advanced video hosting and editing needs, Streamable is perfect for you. Get started today at https://streamable.com .
About Jamm
Jamm is a virtual workplace application that enables lightweight voice and video collaboration for remote teams. Jamm aims to unlock more spontaneous connections and short bursty conversations in the workplace. With powerful collaboration features like screen-sharing, white-boarding, recorded video stories and more — unlock your team’s full potential with Jamm. Try it out now at https://jamm.app .
View source version on businesswire.com: https://www.businesswire.com/news/home/20210323005439/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Biocytogen and Acepodia Expand Collaboration Through Option-based Evaluation Framework for First-in-Class Bispecific and Dual-Payload ADCs (BsAD2C)9.1.2026 13:00:00 CET | Press release
Expanded collaboration builds on Acepodia and Biocytogen’s recent co-development efforts to evaluate selected bispecific antibody and dual-payload ADC programs Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315) and Acepodia (6976:TT), today announced that the companies have entered into an option and license agreement designed to enable the structured evaluation of bispecific antibody-drug conjugate (BsADC) programs to further advance the development of dual-payload bispecific antibody-drug conjugates (BsAD2Cs). The agreement grants Acepodia an option to obtain an exclusive worldwide license from Biocytogen for two BsADC programs. Under the terms of the agreement, Biocytogen is eligible to receive an upfront option fee and, upon Acepodia’s exercise of the option, additional payments including option exercise fees, development, regulatory, and commercial milestone payments, as well as royalties on future product sales. The financial terms of the agreem
Blockstream Capital Partners Announces Strategic Acquisition of Derivatives Trading Team from Numeus Group, Leveraging Strategic Partnership with Komainu9.1.2026 11:08:00 CET | Press release
Blockstream Capital Partners (“BCP”) today announced that it has entered into a strategic agreement to acquire a division within Numeus Group’s digital asset trading and investment business. The transaction includes the absorption of select Bitcoin focused trading strategies with a focus on yield generation as well as a ten person derivatives trading team led by Chief Investment Officer Deepak Gulati, a specialist in volatility and derivatives markets. Deepak Gulati, appointed Co-Chief Investment Officer of Blockstream Capital Management alongside Rodrigo Rodriguez, previously served as Global Head of Proprietary Trading at JPMorgan, before founding Argentiere Capital, a multibillion-dollar volatility-focused hedge fund. With a thesis that derivatives would drive Bitcoin and digital asset market maturity, he co-founded Numeus Group in 2021 to develop institutional-grade trading, risk management and market-structure capabilities. Komainu, an existing BCP strategic investment, has played
Autel Unveils Strategic Shift at CES 2026: Building the AI-Powered Infrastructure of Future Cities9.1.2026 10:44:00 CET | Press release
At the Consumer Electronics Show (CES), Autel Energy is presenting its latest AI-driven smart hardware and software systems for the future of intelligent urban operations. This year’s showcase highlights Autel’s shift from AI concept validation to scenario-based engineering deployment, emphasizing closed-loop execution across real-world infrastructure. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260101511436/en/ Autel Energy New Product Debut at CES 2026 Focusing on two key domains — Smart Energy and Smart Inspection — the company is unveiling a range of new products. In Smart Energy, Autel is introducing V2G (Vehicle-to-Grid) AC charger for homes and DC charging solution for fleets, strengthening its multi-tier energy touchpoint strategy from households to commercial operations. Live demonstrations at the booth will feature a smart charging robot showcasing automated plug-in capabilities. In Smart Inspection, Autel will
Allianz and Anthropic Forge Global Partnership to Advance Responsible AI in Insurance9.1.2026 10:00:00 CET | Press release
Anthropic’s safety-first AI meets Allianz's dedication to customer centricity, stakeholder trust, and regulatory excellenceThree focus areas of the partnership: workforce empowerment, operations automation through agentic AI, and regulatory compliance Allianz SE and Anthropic today announced a global partnership to accelerate the adoption of responsible Artificial Intelligence (AI) at Allianz. The collaboration centers on three transformative projects within Allianz Group designed to empower Allianz employees and accelerate operations, while setting new benchmarks for accuracy. “With this partnership, Allianz is taking a decisive step to address critical AI challenges in insurance. Anthropic’s focus on safety and transparency complements our strong dedication to customer excellence and stakeholder trust. Together, we are building solutions that prioritize what matters most to our customers while setting new standards for innovation and resilience,” said Oliver Bäte, CEO of Allianz SE.
MRM Health Secures FDA IND Clearance to Launch its Phase 2b Trial of MH002 in Mild-to-Moderate Ulcerative Colitis9.1.2026 07:00:00 CET | Press release
MH002 is currently the most advanced Live Biotherapeutic Product (LBP) based on a rationally-designed combination of disease specific bacteria (microbial consortia), for the treatment of inflammatory bowel diseases (IBD) STARFISH-UC Phase 2b trial is designed to confirm MH002’s early efficacy signals and favorable safety observed in Phase 2a studies MRM Health NV, a clinical-stage biopharmaceutical company pioneering microbiome-based therapeutics for inflammatory diseases and immune-oncology, today announced that the U.S. Food and Drug Administration (FDA) has granted clearance of its Investigational New Drug (IND) application for its lead program MH002. This enables the initiation of the STARFISH-UC Phase 2b clinical trial in patients with mild-to-moderate ulcerative colitis, marking a significant step forward in the development of next-generation therapies for inflammatory bowel diseases (IBD). About the STARFISH-UC Phase 2b Trial The STARFISH-UC trial is a randomized, double-blind,
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom